Olmesartan Medoxomil in Hypertension and Renal Impairment

Clinical trial NCT00151827 · COMPLETED

Trial details

NCT number: NCT00151827
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension Renal Impairment

Start date: 2003-08-01
Primary completion: 2005-07-01
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.